Chemomab Therapeutics Ltd. Sponsored ADR CMMB 深 滬
等待開盤 10-21 09:30:00 美东时间
3.40
+0.080
+2.41%
華盛通- 最 高3.45
- 今 開3.38
- 成交量 21.13万股
- 最 低 3.27
- 昨 收 3.32
- 總市值 7059.86万
- 52周最高 9.84
- 市盈率 靜 --
- 換手率 1.02%
- 52周最低 2.39
- 委 比 26.69%
- 總股本 2076.43万
- 歷史最高 736.00
- 量 比 1.15
- 振 幅 5.42%
- 歷史最低 1.68
- 每 手 1
- 風險率 1.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Collective Mining Increases Previously Announced Bought Deal Financing to C$125 Million
Collective Mining Ltd. has increased the size of its stock offering to 6.6 million shares at C$19 each, raising C$125 million. The offering includes an option for underwriters to buy up to an additional 990,000 shares, potentially increasing total proceeds to C$144 million. The funds will support the Guayabales Project and other exploration efforts. The offering is expected to close on October 8, 2025, subject to regulatory approvals.
10-02 13:11
Chemomab Therapeutics Advances Phase 3 Plans for Nebokitug
Chemomab Therapeutics Ltd. ( ($CMMB) ) has released its Q2 earnings. Here is a ...
09-13 11:50
美股大行评级 | 最高至425美元！MONGODB获多家机构上调目标价；德银上调回声星通信(SATS)目标价升至67美元
今日重点评级关注：Oppenheimer：维持Chemomab Therapeutics"跑赢大市"评级，目标价从10美元升至25美元；花旗：维持MongoDB"买入"评级，目标价从405美元升至425美元
08-28 09:51
Oppenheimer Maintains Outperform on Chemomab Therapeutics, Raises Price Target to $25
Oppenheimer analyst Jeff Jones maintains Chemomab Therapeutics (NASDAQ:CMMB) with a Outperform and raises the price target from $10 to $25.
08-28 00:22
Silk Wave Inc Clarifies Dividend Announcement Typo
CMMB Vision Holdings ( ($HK:0471) ) has issued an announcement. Silk Wave Inc i...
08-25 12:40
Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025
Chemomab Therapeutics ( ($CMMB) ) has shared an update. Chemomab Therapeutics L...
08-23 04:28
Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
Chemomab Therapeutics Ltd. announced that its CEO, Dr. Adi Mor, will deliver a corporate presentation at the H.C. Wainwright 27th Annual Global Investment Conference. The prerecorded webcast will be available starting September 5, 2025, at 7:00 am ET, accessible via the provided link. Chemomab management will also host 1x1 investor meetings on September 8 and 9. The company is focused on developing innovative therapeutics for fibro-inflammatory d...
08-21 12:00
Chemomab Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.
Chemomab Therapeutics shares are trading higher after the company reported bett...
08-14 20:39
Chemomab Therapeutics Q2 EPS $(0.00) Beats $(0.07) Estimate
Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.00) per share which beat the analyst consensus estimate of $(0.07) by 94.67 percent. This is a 69.23 percent increase over losses of $(0.01) per share
08-14 20:10
Silkwave Inc Announces Board Changes with New Appointment
An announcement from CMMB Vision Holdings ( ($HK:0471) ) is now available. Silk...
08-12 21:12
